Pingtung County, Taiwan

Mei-Chin Lu

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.9

ph-index = 1


Company Filing History:


Years Active: 2014-2019

Loading Chart...
4 patents (USPTO):

Title: Innovations and Contributions of Inventor Mei-Chin Lu

Introduction

Mei-Chin Lu is a notable inventor based in Pingtung County, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 4 patents to his name, his work has garnered attention for its innovative approaches to combating cancer.

Latest Patents

Among his latest patents, Mei-Chin Lu has developed scalarane sesterterpenoids and a pharmaceutical composition that acts as a topoisomerase II and Hsp90 inhibitor for treating cancer. This invention discloses scalarane sesterterpenoids represented by specific formulas, which are extracted from sponges. The compounds can be utilized as anticancer agents, targeting topoisomerase II and Hsp90. Additionally, he has created a preparation method for a water extract of the fruiting body of a specific species, which enhances T cell proliferation and can be effectively applied in cancer immunotherapy.

Career Highlights

Mei-Chin Lu has worked at prominent institutions such as Kaohsiung Medical University and National Dong Hwa University. His research has focused on developing innovative solutions for cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Throughout his career, Mei-Chin Lu has collaborated with notable colleagues, including Ying-Chi Du and Yang-Chang Wu. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Mei-Chin Lu's contributions to cancer treatment through his innovative patents highlight his role as a significant inventor in the pharmaceutical field. His work continues to inspire advancements in medical research and cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…